Phase II study of bendamustine in combination with rituximab as first-line treatment in patients 80 years or older with aggressiven         B-cell lymphomas

E. Jäger

首页> 外文期刊>Annals of Oncology >Phase II study of bendamustine in combination with rituximab as first-line treatment in patients 80 years or older with aggressiven B-cell lymphomas

【24h】

Phase II study of bendamustine in combination with rituximab as first-line treatment in patients 80 years or older with aggressiven B-cell lymphomas

机译：苯达莫司汀联合利妥昔单抗作为一线治疗在80岁以上侵袭性B细胞淋巴瘤患者中的二期研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Rituximab plus combination chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) is widely recommended for the treatment of aggressive B-cell lymphomas. However, there is very little information regarding the management of elderly patients.

机译：背景：广泛推荐利妥昔单抗联合环磷酰胺，阿霉素，长春新碱和泼尼松联合化疗（R-CHOP）治疗侵袭性B细胞淋巴瘤。但是，关于老年患者管理的信息很少。

著录项

来源
《Annals of Oncology》 |2011年第8期|p.1839-1844|共6页
作者
E. Jäger;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Phase II study of bendamustine in combination with rituximab as first-line treatment in patients 80 years or older with aggressive B-cell lymphomas. [J] . Weidmann E, Neumann A, Fauth F, Annals of oncology: official journal of the European Society for Medical Oncology . 2011,第8期

机译：苯达莫司汀联合利妥昔单抗作为80岁或80岁以上侵袭性B细胞淋巴瘤患者的一线治疗的II期研究。
2. Rituximab plus bendamustine as front-line treatment in frail elderly (70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the Fondazione Italiana Linfomi [J] . Sergio Storti, Michele Spina, Emanuela Anna Pesce, Haematologica . 2018,第8期

机译：利妥昔单抗联合苯达莫司汀作为弱龄老年人（> 70岁）弥漫性大B细胞非霍奇金淋巴瘤患者的一线治疗： Fondazione Italiana Linfomi 的II期多中心研究
3. Results of the Primary Analysis of Complement A plus B: A Phase III Study of Ofatumumab in Combination with Bendamustine Versus Bendamustine Alone in Patients with Indolent Non-Hodgkin's Lymphoma That Is Unresponsive Following Rituximab or Rituximab-Containing Regimen [J] . Rummel Mathias J., Janssens Ann, MacDonald David, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：补体A PLUS B的初步分析结果：单独与苯妥汀与苯妥甘蔗丝蛋白相结合的III类研究，其单独在惰性非霍奇金淋巴瘤患者中，含有鲁妥昔单抗或含人民肢体方案的淋巴瘤无响应
4. Results of treatment of the patients with II~(nd)-III~(rd) st. breast cancer by combination of low level laer therapy (LLLT) and surgery (10-year experience) [C] . V.A.Mikhailov, I.N.Densiov, G.A.Frank, Conference on Laser Florence'99: A Window on the Laser Medicine World 28-31 October 1999 Florence, Italy . 1999

机译：II〜（nd）-III〜（rd）st患者的治疗结果。低水平激光疗法（LLLT）和手术相结合的乳腺癌（10年经验）
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Rituximab plus bendamustine as front-line treatment in frail elderly (70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the Fondazione Italiana Linfomi [O] . Sergio Storti, Michele Spina, Emanuela Anna Pesce, 2018

机译：利妥昔单抗联合苯达莫司汀作为弱龄老年人（ 70岁）弥漫性大B细胞非霍奇金淋巴瘤患者的一线治疗：Fondazione Italiana Linfomi的II期多中心研究
7. Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the Fondazione Italiana Linfomi [O] . Sergio Storti, Michele Spina, Emanuela Anna Pesce, 2018

机译：Rituximab Plus Bendamustine作为Frillual（> 70年）弥漫性大B细胞非霍奇金淋巴瘤患者的前线治疗患者：II期的Fondazione Italiana Linfomi的多中心研究

Phase II study of bendamustine in combination with rituximab as first-line treatment in patients 80 years or older with aggressiven B-cell lymphomas

摘要

著录项

相似文献

相关主题

期刊订阅